PCM
GWPH

Prelude Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Prelude Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,653
Closed -$4.05M – 2156
2021
Q1 		$4.05M Buy
+18,653
New +$3.51M 0.1% 130
2020
Q1 		– Sell
-9,277
Closed -$970K – 2255
2019
Q4 		$970K Buy
9,277
+9,147
+7,036% +$1.03M 0.04% 398
2019
Q3 		$15K Sell
130
-14
-10% -$2.13K ﹤0.01% 1440
2019
Q2 		$25K Sell
144
-935
-87% -$162K ﹤0.01% 1256
2019
Q1 		$182K Sell
1,079
-2,141
-66% -$319K 0.01% 744
2018
Q4 		$314K Buy
3,220
+680
+27% +$89.2K 0.02% 598
2018
Q3 		$439K Sell
2,540
-1,673
-40% -$241K 0.03% 563
2018
Q2 		$588K Sell
4,213
-930
-18% -$132K 0.04% 486
2018
Q1 		$579K Buy
5,143
+2,151
+72% +$270K 0.04% 405
2017
Q4 		$395K Buy
+2,992
New +$352K 0.03% 475
2016
Q4 		– Sell
-2,483
Closed -$330K – 1880
2016
Q3 		$330K Buy
+2,483
New +$237K 0.03% 409
2013
Q4 		– Sell
-11,000
Closed -$191K – 2023
2013
Q3 		$191K Buy
+11,000
New +$126K 0.03% 557

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Prelude Capital Management's GWPH Position: Q2 2021 in Review

Prelude Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 18,653 shares — an estimated $4.05M sold.

Prelude Capital Management first reported a position in GWPH in Q3 2013 and held it in 12 quarters. The position peaked at $4.05M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Prelude Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Prelude Capital Management sold 18,653 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.05M.
  • Prelude Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2013 and held it in 12 quarters.
  • Prelude Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.05M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.